LMU Medizinische Fakultät IBE IBE
Home  |  Sitemap  |  RSS RSS  |  www.lmu.de  |  Medizinische Fakultät  |  LMU-Portal
IBE - Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie


(Impact-Faktor aus 2011)

Achleitner U, Coenen M, Colombel JF, Biroulet L, Sahakyan N, Cieza A
Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures
J Crohns Colitis. 2012 Jun;6(5):507-17. Epub 2011 Dec 8. Impact-Faktor 2.566
Adrion C, Mansmann U
Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: An example from a vertigo phase III study with longitudinal count data as primary endpoint
BMC Med Res Methodol. 2012 Sep 10;12(1):137. Impact-Faktor 2.668
Alguren B, Fridlund B, Cieza A, Sunnerhagen KS, Christensson L
Factors associated with health-related quality of life after stroke: a 1-year prospective cohort study
Neurorehabil Neural Repair. 2012 Mar-Apr;26(3):266-74. Epub 2011 Aug 8. Impact-Faktor 4.495
Allgayer H, Ignee A, Zipse S, Crispin A, Dietrich CF
Endorectal Ultrasound and Real-Time Elastography in Patients with fecal Incontinence Following Anorectal Surgery: A Prospective Comparison Evaluating Short- and Long-Term Outcomes in Irradiated and Non-Irradiated Patients
Z Gastroenterol. 2012 Dec;50(12):1281-1286. Impact-Faktor 0,896
Allinson S, Asmuss M, Baldermann C, Bentzen J, Buller D, Gerber N, Green AC, Greinert R, Kimlin M, Kunrath J, Matthes R, Viol C, Rehfuess E, Rossmann C, Schuz N, Sinclair C, Deventer Ev, Webb A, Weiss W, Ziegelberger G
Validity and use of the UV index: report from the UVI working group, Schloss Hohenkammer, Germany, 5-7 December 2011
Health Phys. 2012 Sep;103(3):301-6. Impact-Faktor 1.680
Amann C, Hasford J, Stausberg J
[Hospital Admission due to Adverse Drug Events (ADE): An Analysis of German Routine Hospital Data of 2006]
Gesundheitswesen. 2012 Oct;74(10):639-44. Impact-Faktor 0.937
Andrassy J, Hoffmann VS, Rentsch M, Stangl M, Habicht A, Meiser B, Fischereder M, Jauch KW, Guba M
Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor-Based Immunosuppression? A Systematic Review and Meta-Analysis
Transplantation. 2012 Dec 27;94(12):1208-1217. Impact-Faktor 4.003
Averbeck B, Rucker F, Laubender RP, Carr RW
Thermal grill-evoked sensations of heat correlate with cold pain threshold and are enhanced by menthol and cinnamaldehyde
Eur J Pain. 2012 Nov 9;():. Impact-Faktor 3.939
Avila CC, Cieza A, Anaya C, Mateos JL
The patients' perspective on relevant areas and problems in the bipolar spectrum disorder: individual interviews using the International Classification of Functioning, Disability and Health as a reference tool
Am J Phys Med Rehabil. 2012 Feb;91(13 Suppl 1):S181-8. Impact-Faktor 1.581
Ballert C, Oberhauser C, Sorensen F, Stucki G, Cieza A
Explanatory power does not equal clinical importance: study of the use of the Brief ICF Core Sets for Spinal Cord Injury with a purely statistical approach
Spinal Cord. 2012 Apr 24. doi: 10.1038/sc.2012.40. [Epub ahead of print] Impact-Faktor 1.805
Baumbach SF, Dall’Ara E, Weninger P, Antoni A, Traxler H, Dörr M, Zysset PK
Assessment of a novel biochemical fracture model for distal radius fractures

BMC Musculoskeletal Disorders 2012;13:252. Impact-Faktor 1.577

Becker K, Reim D, Novotny A, Buschenfelde CM, Engel J, Friess H, Hofler H, Langer R
Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery
Ann Surg. 2012 Sep 10;():. Impact-Faktor 7.492
Beigel F, Lohr B, Laubender RP, Tillack C, Schnitzler F, Breiteneicher S, Weidinger M, Goke B, Seiderer J, Ochsenkuhn T, Brand S
Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease
Digestion. 2012;85(1):47-54. Epub 2011 Dec 14. Impact-Faktor 2.046
Beji A, Horst D, Engel J, Kirchner T, Ullrich A
Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer
Clin Cancer Res. 2012 Feb 15;18(4):956-68. Epub 2011 Dec 5. Impact-Faktor 7.742
Bernau C, Boulesteix AL, Knaus J
Application of Microarray Analysis on Computer Cluster and Cloud Platforms
Methods Inf Med. 2012 Nov 27;52(1):. Impact-Faktor 1.472
Berno S, Coenen M, Leib A, Cieza A, Kesselring J
Validation of the Comprehensive International Classification of Functioning, Disability, and Health Core Set for multiple sclerosis from the perspective of physicians
J Neurol. 2012 Aug;259(8):1713-26. Epub 2012 Jan 24. Impact-Faktor 3.473
Boeck S, Jung A, Laubender RP, Neumann J, Egg R, Goritschan C, Kaiser U, Winkelmann C, Weikersthal L, Clemens MR, Gauler TC, Marten A, Klein S, Kojouharoff G, Barner M, Geissler M, Greten TF, Mansmann U, Kirchner T, Heinemann V
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104
Br J Cancer. 2012 Nov 20;():. Impact-Faktor 4.346
Bostan C, Oberhauser C, Cieza A
Investigating the dimension functioning from a condition-specific perspective and the qualifier scale of the International Classification of Functioning, Disability, and Health based on Rasch analyses
Am J Phys Med Rehabil. 2012 Feb;91(13 Suppl 1):S129-40. Impact-Faktor 1.581
Buechner T, Schlenk RF, Schaich M, Doehner K, Krahl R, Krauter J, Heil G, Krug U, Sauerland MC, Heinecke A, Spaeth D, Kramer M, Scholl S, Berdel WE, Hiddemann W, Hoelzer D, Hehlmann R, Hasford J, Hoffmann VS, Doehner H, Ehninger G, Ganser A, Niederwieser DW, Pfirrmann M
Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm--Combined Prospective Analysis by the German AML Intergroup
J Clin Oncol. 2012 Oct 10;30(29):3604-10. Impact-Faktor 18.372
Burford BJ, Rehfuess E, Schunemann HJ, Akl EA, Waters E, Armstrong R, Thomson H, Doyle J, Pettman T
Assessing evidence in public health: the added value of GRADE
J Public Health (Oxf). 2012 Dec;34(4):631-5.
Cabello M, Marsa B, Sabariego C, Cieza A, Bickenbach J, Mateos JL
Psychosocial features of depression: A systematic literature review
J Affect Disord. 2012 Dec 1;141(1):22-33. Impact-Faktor 3.517
Cadicamo CD, Mortier J, Wolber G, Hell M, Heinrich IE, Michel D, Semlin L, Berger U, Korting HC, Holtje HD, Koksch B, Borelli C
Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues adressing different secreted aspartic proteinases of Candida albicans
Biochem Pharmacol. 2012 Dec 20;():. Impact-Faktor 4.705
Canis M, Lechner A, Mack B, Zengel P, Laubender RP, Koehler U, Heissmeyer V, Gires O
CD133 induces tumour-initiating properties in HEK293 cells
Tumour Biol. 2012 Nov 13;():. Impact-Faktor 2.143
Coenen M, Stamm TA, Stucki G, Cieza A
Individual interviews and focus groups in patients with rheumatoid arthritis: a comparison of two qualitative methods
Qual Life Res. 2012 Mar;21(2):359-70. Epub 2011 Jun 25. Impact-Faktor 2.300
Conrad A, Coenen M, Schmalz H, Kesselring J, Cieza A
Validation of the Comprehensive ICF Core Set for Multiple Sclerosis From the Perspective of Physical Therapists
Phys Ther. 2012 Jun;92(6):799-820. Epub 2012 Mar 8. Impact-Faktor 3.113
Conrad A, Coenen M, Schmalz H, Kesselring J, Cieza A
Validation of the Comprehensive ICF Core Set for Multiple Sclerosis from the perspective of occupational therapists
Scand J Occup Ther. 2012 Mar 20. [Epub ahead of print] Impact-Faktor 1.070
Cucuruz B, Dango S, Jurinovic V, Mayer O, Follo M, Bohm J, Freudenberg N, Elze M, Sienel W, Klein CA, Passlick B, Polzer B
MAGE qPCR improves the sensitivity and accuracy of EBUS-TBNA for the detection of lymphatic cancer spread
J Thorac Oncol. 2012 Apr;7(4):690-7. Impact-Faktor 3.661
Dreyling M, Nelemans HC, Bea S, Klapper W, Vogt N, Larue MH, Hutter G, Cheah C, Chiappella A, Cortelazzo S, Pott C, Hess G, Visco C, Vitolo U, Klener P, Aurer I, Unterhalt M, Ribrag V, Hoster E, Hermine O
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma - report of the 11(th) annual conference of the EUROPEAN MANTLE CELL LYMPHOMA NETWORK
Leuk Lymphoma. 2012 Sep 28;():. Impact-Faktor 2.580
Dufour A, Schneider F, Hoster E, Benthaus T, Ksienzyk B, Schneider S, Kakadia PM, Sauerland MC, Berdel WE, Buchner T, Wormann B, Braess J, Subklewe M, Hiddemann W, Bohlander SK, Spiekermann K
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients
Ann Hematol. 2012 Jul;91(7):1051-63. Epub 2012 Feb 24. Impact-Faktor 2.615
Engel J, Emeny RT, Hoelzel D
Positive lymph nodes do not metastasize
Cancer Metastasis Rev. 2012 Jun;31(1-2):235-46. Impact-Faktor 10.573
Engelstaedter V, Boda J, Volklein C, Engel J, Jeschke U, Kirchner T, Mayr D
Lack of prognostic relevance of Her-2/neu, topoisomerase IIalpha and EGFR in advanced ovarian carcinoma
Exp Ther Med. 2012 May;3(5):828-834. Impact-Faktor 0.206
Engelstaedter V, Schiffers J, Kahlert S, Mainka P, Engel J, Kirchner T, Diebold J, Mayr D
Her-2/neu and topoisomerase IIalpha in advanced breast cancer: a comprehensive FISH analysis of 245 cases
Diagn Mol Pathol. 2012 Jun;21(2):77-83. Impact-Faktor 2.257
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, Fouchardiere C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Muller HH, Skogseid B
Combination chemotherapy in advanced adrenocortical carcinoma
N Engl J Med. 2012 Jun 7;366(23):2189-97. Epub 2012 May 2. Impact-Faktor 53.298
Fayed N, Cieza A, Bickenbach J
Illustrating child-specific linking issues using the Child Health Questionnaire
Am J Phys Med Rehabil. 2012 Feb;91(13 Suppl 1):S189-98. Impact-Faktor 1.581
Fayed N, , Kerr E, Rosenbaum P, Dubey A, Bostan C, Faulhaber M, Raina P, Cieza A
Generic patient-reported outcomes in child health research: a review of conceptual content using World Health Organization definitions
Dev Med Child Neurol. 2012 Aug 22;():. Impact-Faktor 2.918
Finger ME, Escorpizo R, Glassel A, Gmunder HP, Luckenkemper M, Chan C, Fritz J, Studer U, Ekholm J, Kostanjsek N, Stucki G, Cieza A
ICF Core Set for vocational rehabilitation: results of an international consensus conference
Disabil Rehabil. 2012;34(5):429-38. Epub 2011 Oct 10. Impact-Faktor 1.498
Flexeder C, Thiering E, Bruske I, Koletzko S, Bauer CP, Wichmann HE, Mansmann U, Berg A, Berdel D, Kramer U, Schaaf B, Lehmann I, Herbarth O, Heinrich J
Growth velocity during infancy and onset of asthma in school-aged children
Allergy. 2012 Feb;67(2):257-64. doi: 10.1111/j.1398-9995.2011.02748.x. Epub 2011 Nov 18. Impact-Faktor 6.271
Freydanck MK, Laubender RP, Rack B, Schuhmacher L, Jeschke U, Scholz C
Two-marker Combinations for Preoperative Discrimination of Benign and Malignant Ovarian Masses
Anticancer Res. 2012 May;32(5):2003-8. Impact-Faktor 1.656
Fritsche LG, Fleckenstein M, Fiebig BS, Valckenberg S, Wittich A, Keilhauer CN, Renner AB, Mackensen F, Moessner A, Pauleikhoff D, Adrion C, Mansmann U, Scholl HP, Holz FG, Weber BH
A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene
Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2112-8. doi: 10.1167/iovs.11-8785. Print 2012. Impact-Faktor 3.597
Germing U, Lauseker M, Hildebrandt B, Symeonidis A, Cermak J, Fenaux P, Kelaidi C, Pfeilstocker M, Nosslinger T, Sekeres M, Maciejewski J, Haase D, Schanz J, Seymour J, Kenealy M, Weide R, Lubbert M, Platzbecker U, Valent P, Gotze K, Stauder R, Blum S, Kreuzer KA, Schlenk R, Ganser A, Hofmann WK, Aul C, Krieger O, Kundgen A, Haas R, Hasford J, Giagounidis A
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
Leukemia. 2012 Jun;26(6):1286-92. doi: 10.1038/leu.2011.391. Epub 2012 Jan 13. Impact-Faktor 9.561
Giessen C, Laubender RP, Ankerst DP, Stintzing S, Modest DP, Mansmann U, Heinemann V
Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in mCRC: Literature-Based Analysis from 50 Randomized First-Line Trials
Clin Cancer Res. 2012 Nov 13;():. Impact-Faktor 7.742
Glaessel A, Coenen M, Kollerits B, Cieza A
Validation of the extended ICF core set for stroke from the patient perspective using focus groups
Disabil Rehabil. 2012;34(2):157-66. Epub 2011 Oct 4. Impact-Faktor 1.498
Greif PA, Dufour A, Konstandin NP, Ksienzyk B, Zellmeier E, Tizazu B, Sturm J, Benthaus T, Herold T, Yaghmaie M, Dorge P, Hopfner KP, Hauser A, Graf A, Krebs S, Blum H, Kakadia PM, Schneider S, Hoster E, Schneider F, Stanulla M, Braess J, Sauerland MC, Berdel WE, Buchner T, Woermann BJ, Hiddemann W, Spiekermann K, Bohlander SK
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
Blood. 2012 Jul 12;120(2):395-403. Epub 2012 May 30. Impact-Faktor 9.898
Grill E, Bronstein A, Furman J, Zee DS, Mueller M
International Classification of Functioning, Disability and Health (ICF) Core Set for patients with vertigo, dizziness and balance disorders
J Vestib Res. 2012 June 1;22(5):261-71. Impact-Faktor 1.350
Grone E, Crispin A, Fleckenstein J, Irnich D, Treede RD, Lang PM
Test order of quantitative sensory testing facilitates mechanical hyperalgesia in healthy volunteers
J Pain. 2012 Jan;13(1):73-80. Impact-Faktor 4.926
Grunke M, Witt MN, Ronneberger M, Schnez A, Laubender RP, Engelbrecht M, Kavanaugh A, Koops H
Use of the 28-Joint Count Yields Significantly Higher Concordance Between Different Examiners Than the 66/68-Joint Count
J Rheumatol. 2012 Jul;39(7):1334-40. Epub 2012 Jun 1. Impact-Faktor 3.695
Haas M, Laubender RP, Klose C, Schulz C, Mansmann U, Boeck S, Heinemann V
External Validation of 2 Prognostic Indices for Patients With Advanced Pancreatic Cancer Treated With First-line Therapy
Pancreas. 2012 Jul;41(5):738-44. Impact-Faktor 2.386
Hanfstein B, Muller MC, Hehlmann R, Erben P, Lauseker M, Fabarius A, Schnittger S, Haferlach C, Gohring G, Proetel U, Kolb HJ, Krause SW, Hofmann WK, Schubert J, Einsele H, Dengler J, Hanel M, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Branford S, Hughes TP, Spiekermann K, Baerlocher GM, Pfirrmann M, Hasford J, Saussele S, Hochhaus A
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
Leukemia. 2012 Mar 26. doi: 10.1038/leu.2012.85. [Epub ahead of print] Impact-Faktor 9.561
Hansson MG, Simonsson B, Feltelius N, Forsberg JS, Hasford J
Medical registries represent vital patient interests and should not be dismantled by stricter regulation
Cancer Epidemiol. 2012 Jul 13;():. Impact-Faktor 2.010
Herold T, Mulaw MA, Jurinovic V, Seiler T, Metzeler KH, Dufour A, Schneider S, Kakadia PM, Spiekermann K, Mansmann U, Hiddemann W, Buske C, Dreyling M, Bohlander SK
High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature
Leuk Lymphoma. 2012 Dec 27;():.
Heumuller S, Stausberg J, Jockel KH
[Neurological complex treatment - impact on mortality in the first year and costs for statutory health insurance]
Fortschr Neurol Psychiatr. 2012 Oct;80(10):593-8. Impact-Faktor 0,741
Hoerbrand F, Bramlage P, Fischaleck J, Hasford J, Brunkhorst R
A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemia
Eur J Clin Pharmacol. 2012 Oct 2;():.
Hoffmann V, Baccarani M, Hasford J, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R
The EUTOS CML score aims to support clinical decision-making
Blood. 2012 Mar 22;119(12):2966-7. Impact-Faktor 9.898
Hofheinz RD, Heinemann V, Weikersthal LF, Laubender RP, Gencer D, Burkholder I, Hochhaus A, Stintzing S
Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer
Br J Cancer. 2012 Oct 2;():. Impact-Faktor 4.346
Hornuss C, Zagler A, Dolch ME, Wiepcke D, Praun S, Boulesteix AL, Weis F, Apfel CC, Schelling G
Breath isoprene concentrations in persons undergoing general anesthesia and in healthy volunteers
J Breath Res. 2012 Nov 15;6(4):046004. Impact-Faktor 2.541
Hunger M, Sabariego C, Stollenwerk B, Cieza A, Leidl R
Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation
Qual Life Res. 2012 Sep;21(7):1205-16. Impact-Faktor 2.300
Italia N, Rehfuess EA
Is the Global Solar UV Index an effective instrument for promoting sun protection? A systematic review
Health Educ Res. 2012 Apr;27(2):200-13. Impact-Faktor 1.656
Kiderlen M, Bastiaannet E, Walsh PM, Keating NL, Schrodi S, Engel J, Water W, Ess SM, Eycken L, Miranda A, Munck L, Velde CJ, Craen AJ, Liefers GJ
Surgical treatment of early stage breast cancer in elderly: an international comparison
Breast Cancer Res Treat. 2012 Apr;132(2):675-82.
Nelemans HC, Hoster E, Hermine O, Walewski J, Trneny M, Geisler CH, Stilgenbauer S, Thieblemont C, Kaiser U, Doorduijn JK, Coiffier B, Forstpointner R, Tilly H, Kanz L, Feugier P, Szymczyk M, Hallek M, Kremers S, Lepeu G, Sanhes L, Zijlstra JM, Bouabdallah R, Lugtenburg PJ, Macro M, Pfreundschuh M, Prochazka V, Raimondo F, Ribrag V, Uppenkamp M, Andre M, Klapper W, Hiddemann W, Unterhalt M, Dreyling MH
Treatment of older patients with mantle-cell lymphoma
N Engl J Med. 2012 Aug 9;367(6):520-31. Impact-Faktor 53.298
Koch K, Hoster E, Unterhalt M, Ott G, Rosenwald A, Hansmann ML, Engelhard M, Hiddemann W, Klapper W
The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease
Hum Pathol. 2012 Jul 13;():. Impact-Faktor 2.876
Kolligs FT, Crispin A, Graser A, Munte A, Mansmann U, Goke B
Risk factors for advanced neoplasia within subcentimetric polyps: implications for diagnostic imaging
Gut. 2012 Apr 23. [Epub ahead of print] Impact-Faktor 10.111
Kuehlmeyer K, Racine E, Palmour N, Hoster E, Borasio GD, Jox RJ
Diagnostic and ethical challenges in disorders of consciousness and locked-in syndrome: a survey of German neurologists
J Neurol. 2012 Mar 10. [Epub ahead of print] Impact-Faktor 3.473
Kuendgen A, Lauseker M, List AF, Fenaux P, Giagounidis AA, Brandenburg NA, Backstrom J, Glasmacher A, Hasford J, Germing AU
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis
Leukemia. 2012 Dec 21;():.
Kuhnisch J, Mansmann U, Weltzien R, Hickel R
Longevity of materials for pit and fissure sealing--results from a meta-analysis
Dent Mater. 2012 Mar;28(3):298-303. Epub 2011 Dec 3. Impact-Faktor 3.135
Kus S, Oberhauser C, Cieza A
Validation of the Brief International Classification of Functioning, Disability, and Health (ICF) Core Set for Hand Conditions
J Hand Ther. 2012 Jul;25(3):274-87. Epub 2012 May 7. Impact-Faktor 1.556
Lange T, Ernst T, Gruber F, Maier J, Cross M, Muller MC, Niederwieser D, Hochhaus A, Pfirrmann M
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia
Haematologica. 2012 Oct 12;():. Impact-Faktor 6.532
Lauseker M, Pfirrmann M, Hoffmann VS, Hasford J
Comment on "Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed" Haematologica 2011;96(12):1779-82
Haematologica. 2012 May;97(5):e14-5. Impact-Faktor 6.532
Laxe S, Tschiesner U, Zasler N, Blazquez R, Tormos JM, Bernabeu M
What domains of the International Classification of Functioning, Disability and Health are covered by the most commonly used measurement instruments in traumatic brain injury research?
Clin Neurol Neurosurg. 2012 Jul;114(6):645-50. Epub 2012 Jan 13. Impact-Faktor 1.581
Lehner S, Todica A, Brunner S, Uebleis C, Wang H, Wangler C, Herbach N, Herrler T, Boning G, Laubender RP, Cumming P, Schirrmacher R, Franz W, Hacker M
Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: an in vivo imaging study in mice
Mol Imaging. 2012 Dec 1;11(6):461-70. Impact-Faktor 3.18
Leib A, Cieza A, Tschiesner U
Perspective of physicians within a multidisciplinary team: content validation of the comprehensive ICF core set for head and neck cancer
Head Neck. 2012 Jul;34(7):956-66. Impact-Faktor 2.403
Maier T, Falco M, Laubender RP, Ruzicka T, Berking C
Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology
Br J Dermatol. 2012 Aug 4;():. Impact-Faktor 3.666
Bender A, Kern A, Pollwein B, Crispin A, Lang PM
Incidence and predictors of immediate complications following perioperative non-obstetric epidural punctures
BMC Anesthesiol. 2012 Dec 10;12(1):31.
Ngouongo S, Stausberg J
A ClaML-based Interface for the Import of Monohierarchical Classifications
Stud Health Technol Inform. 2012 ;180():63-7. Impact-Faktor 4.877
Modest DP, Brodowicz T, Stintzing S, Jung A, Neumann J, Laubender RP, Ocvirk J, Kurteva G, Papai Z, Knittelfelder R, Kirchner T, Heinemann V, Zielinski CC
Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials
Oncology. 2012 ;83(5):241-7. Impact-Faktor 0.174
Modest DP, Laubender RP, Stintzing S, Giessen C, Schulz C, Haas M, Mansmann U, Heinemann V
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial
Acta Oncol. 2012 Dec 18;():. Impact-Faktor 3.330
Modest DP, Schick A, Stintzing S, Giessen C, Tannapfel A, Laubender RP, Brodowicz T, Knittelfelder R, Vrbanec D, Schmiegel W, Heinemann V, Zielinski CC
Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis
Anticancer Drugs. 2012 Jul;23(6):666-73. Impact-Faktor 2.407
Mueller M, Schuster E, Strobl R, Grill E
Identification of aspects of functioning, disability and health relevant to patients experiencing vertigo: a qualitative study using the international classification of functioning, disability and health
Health Qual Life Outcomes. 2012 ;10():75. Impact-Faktor 2.112
Mueller O, Meissner P, Mansmann U
Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue
Drug Saf. 2012 Jan 1;35(1):85; author reply 85-6. Impact-Faktor 3.634
Mueller R, Peter C, Cieza A, Geyh S
The role of social support and social skills in people with spinal cord injury--a systematic review of the literature
Spinal Cord. 2012 Feb;50(2):94-106. Impact-Faktor 1.805
Muller O, Mockenhaupt FP, Marks B, Meissner P, Coulibaly B, Kuhnert R, Buchner H, Schirmer RH, Sack I, Sie A, Mansmann U
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs
Pharmacoepidemiol Drug Saf. 2012 Nov 7;():.
Muller R, Cieza A, Geyh S
Rasch analysis of the Hospital Anxiety and Depression Scale in spinal cord injury
Rehabil Psychol. 2012 Aug;57(3):214-23. Impact-Faktor 1.907
Neugebauer H, Adrion C, Glaser M, Strupp M
Long-Term Changes of Central Ocular Motor Signs in Patients with Vestibular Migraine
Eur Neurol. 2012 Nov 23;69(2):102-107.
Neumann J, Horst D, Kriegl L, Maatz S, Engel J, Jung A, Kirchner T
A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer
Histopathology. 2012 Feb;60(3):416-26. Impact-Faktor 3.082
Notohamiprodjo M, Weiss M, Baumeister RG, Sommer WH, Helck A, Crispin A, Reiser MF, Herrmann KA
MR Lymphangiography at 3.0 T: Correlation with Lymphoscintigraphy
Radiology. 2012 Jul;264(1):78-87. Epub 2012 Apr 20. Impact-Faktor 5.726
Ochsenkuhn R, Arzberger A, Schonfeldt V, Gallwas J, Rogenhofer N, Crispin A, Thaler CJ, Noss U
Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers
Fertil Steril. 2012 Aug;98(2):347-54. Epub 2012 May 24. Impact-Faktor 3.775
Peter C, Muller R, Cieza A, Geyh S
Psychological resources in spinal cord injury: a systematic literature review
Spinal Cord. 2012 Mar;50(3):188-201. doi: 10.1038/sc.2011.125. Epub 2011 Nov 29. Impact-Faktor 1.805
Peter C, Rauch A, Cieza A, Geyh S
Stress, internal resources and functioning in a person with spinal cord disease
Neuro Rehabilitation. 2012 Jan 1;30(2):119-30. Impact-Faktor 1.635
Biroulet L, Cieza A, Sandborn WJ, Coenen M, Chowers Y, Hibi T, Kostanjsek N, Stucki G, Colombel JF
Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health
Gut. 2012 Feb;61(2):241-7. Impact-Faktor 10.111
Pfirrmann M, Ehninger G, Thiede C, Bornhauser M, Kramer M, Rollig C, Hasford J, Schaich M
Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial
Lancet Oncol. 2012 Feb;13(2):207-14. Impact-Faktor 22.589
Prodinger B, Salzberger T, Stucki G, Stamm T, Cieza A
Measuring Functioning in People with Fibromyalgia (FM) Based on the International Classification of Functioning, Disability and Health (ICF)-A Psychometric Analysis
Pain Pract. 2012 Apr;12(4):255-265. Impact-Faktor 2.207
Quintas R, Raggi A, Giovannetti AM, Pagani M, Sabariego C, Cieza A, Leonardi M
Psychosocial difficulties in people with epilepsy: A systematic review of literature from 2005 until 2010
Epilepsy Behav. 2012 Sep;25(1):60-7. Impact-Faktor 2.335
Raggi A, Giovannetti AM, Quintas R, Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M
A systematic review of the psychosocial difficulties relevant to patients with migraine
J Headache Pain. 2012 Sep 23;():. Impact-Faktor 2.427
Reiss K, Berger U, Winkler V, Voigtlander S, Becher H, Razum O
Assessing the effect of regional deprivation on mortality avoiding compositional bias: a natural experiment
J Epidemiol Community Health. 2012 Oct 23;():. Impact-Faktor 3.192
Rottenkolber D, Hasford J, Stausberg J
Costs of adverse drug events in german hospitals-a microcosting study
Value Health. 2012 Sep;15(6):868-75. Impact-Faktor 2.191
Rottenkolber D, Schmiedl S, Rottenkolber M, Thuermann PA, Hasford J
Drug-Induced Blood Consumption: The Impact of Adverse Drug Reactions on Demand for Blood Components in German Departments of Internal Medicine
Basic Clin Pharmacol Toxicol. 2012 Apr 6. doi: 10.1111/j.1742-7843.2012.00890.x. [Epub ahead of print] Impact-Faktor 2.179
Rudolf KD, Kus S, Chung KC, Johnston M, LeBlanc M, Cieza A
Development of the International Classification of Functioning, Disability and Health core sets for hand conditions--results of the World Health Organization International Consensus process
Disabil Rehabil. 2012;34(8):681-93. Epub 2011 Oct 6. Impact-Faktor 1.498
Rusner C, Greulich U, Engel J, Stegmaier C, Zawinell A, Holleczek B, Katalinic A, Kuss O, Pokrzywniak A, Fritschle G, Tillack A, Stang A
Population-based hormone receptor-specific incidence trends of breast cancer in Germany
Maturitas. 2012 Oct;73(2):152-7. Impact-Faktor 2.767
Sabariego C, Barrera AE, Neubert S, Jarmer M, Bostan C, Cieza A
Evaluation of an ICF-based patient education programme for stroke patients: A randomized, single-blinded, controlled, multicentre trial of the effects on self-efficacy, life satisfaction and functioning
Br J Health Psychol. 2012 Dec 17;():.
Sattler EC, Maier T, Hoffmann VS, Hegyi J, Ruzicka T, Berking C
Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy
Br J Dermatol. 2012 Nov;167(5):1042-7.
Saussele S, Pfirrmann M
Clinical Trials in Chronic Myeloid Leukemia
Curr Hematol Malig Rep. 2012 Jun;7(2):109-15.
Schleinkofer T, Villain S, Lamla G, Praßer F, Kuhn K, Mansmann U
S3U LMU Prototyp-Infrastruktur für die IT-Unterstützung klinischer Studien am Klinikum der Universität München
Gesellschaft für Informatik, Veröffentlichungsreihe "Lecture Notes in Informatics". 2012 ;():.
Schmidt J, Abel U, Debus J, Harig S, Hoffmann K, Herrmann T, Bartsch D, Klein J, Mansmann U, Jager D, Capussotti L, Kunz R, Buchler MW
Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma
J Clin Oncol. 2012 Sep 24;():. Impact-Faktor 18.372
Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)
Ann Hematol. 2012 Jan;91(1):9-18. Impact-Faktor 2.615
Schneider F, Hoster E, Unterhalt M, Schneider S, Dufour A, Benthaus T, Mellert G, Zellmeier E, Kakadia PM, Bohlander SK, Buske M, Buske C, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Hiddemann W, Spiekermann K
The FLT3ITD level has a high prognostic impact in NPM1 mutated, but not NPM1 unmutated AML with a normal karyotype
Blood. 2012 May 10;119(19):4383-6. Epub 2012 Feb 28. Impact-Faktor 9.898
Schniepp R, Wuehr M, Neuhaeusser M, Benecke AK, Adrion C, Brandt T, Strupp M, Jahn K
4-Aminopyridine and cerebellar gait: a retrospective case series
Journal of Neurology. 2012 Jul 4;(): Impact-Faktor 3.473
Schoenberger K, Riedel C, Ruckinger S, Mansmann U, Jilg W, Kries R
Impact of maternal carrier status on immunologic markers for protection after hepatitis B vaccination in infancy: A meta-analysis
Vaccine. 2012 Sep 28;30(44):6314-26. Impact-Faktor 3.766
Schramm W, Gringeri A, Ljung R, Berger K, Crispin A, Bullinger M, Giangrande PL, Mackensen S, Mantovani LG, Nemes L, Serban M
Haemophilia Care in Europe: the ESCHQoL study
Haemophilia. 2012 May 29. doi: 10.1111/j.1365-2516.2012.02847.x. [Epub ahead of print] Impact-Faktor 2.597
Stange R, Moser C, Hopfenmueller W, Mansmann U, Buehring M, Uehleke B
Randomised controlled trial with medical leeches for osteoarthritis of the knee
Complement Ther Med. 2012 Feb-Apr;20(1-2):1-7. Impact-Faktor 1.872
Stausberg J
[Is multiple trauma currently affordable?]
Unfallchirurg. 2012 May;115(5):467-8. Impact-Faktor 0.610
Stausberg J, Pritzkuleit R, Schmidt CO, Schrader T, Nonnemacher M
Indicators of data quality: revision of a guideline for networked medical research
Stud Health Technol Inform. 2012 ;180():711-5. Impact-Faktor 4.877
Strobl R, Grill E, Mansmann U
Graphical modeling of binary data using the LASSO: a simulation study
BMC Med Res Methodol. 2012 ;12():16. Impact-Faktor 2.668
Switaj P, Anczewska M, Chrostek A, Sabariego C, Cieza A, Bickenbach J, Chatterji S
Disability and schizophrenia: a systematic review of experienced psychosocial difficulties
BMC Psychiatry. 2012 ;12():193.
Titiloye O, Crispin A
Parameter tuning patterns for random graph coloring with quantum annealing
PLoS ONE. 2012 ;7(11):e50060.
Uebleis C, Hellweger S, Laubender RP, Becker A, Sohn HY, Lehner S, Haug A, Bartenstein P, Cumming P, Kriekinge SD, Slomka PJ, Hacker M
Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy
Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1561-9. Impact-Faktor 4.991
Vogler T, Kriegl L, Horst D, Engel J, Sagebiel S, Schaffauer AJ, Kirchner T, Jung A
The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors
Exp Mol Pathol. 2012 Feb;92(1):111-7. Impact-Faktor 2.425
Weissenbacher T, Laubender RP, Witkin SS, Gingelmaier A, Schiessl B, Kainer F, Friese K, Jeschke U, Dian D, Karl K
Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth
Arch Gynecol Obstet. 2012 Nov 29;():. Impact-Faktor 1.277
Weissenbacher TM, Laubender RP, Witkin SS, Gingelmaier A, Schiessl B, Kainer F, Friese K, Jeschke U, Dian D, Karl K
Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid
BMC Res Notes. 2012 Jul 24;5(1):375.
Wolf MC, Zehentmayr F, Schmidt M, Hoelzel D, Belka C
Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre
Radiat Oncol. 2012 ;7():60.


Impressum - Datenschutz - Kontakt